Gilead Sciences Inc
Here’s whether Gilead Sciences Inc (GILD) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Neutral.
Positives: trading above the 200-day MA (long-term uptrend intact); RSI 49 — healthy momentum range; strong 1-year return of +16.9%; rising volume confirms the move (1.26x 30d avg). Concerns: below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-1.39% over 10 days); 3-month momentum negative (-11.9%). Currently 17.9% off its 52-week high. Score: +2/7.
GILD is holding above its long-term 200-day MA ($128.92) but has slipped below the 50-day MA ($134.18), pointing to short-term weakness in an otherwise intact trend. An RSI of 48.9 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +16.9% compares to +24.4% for SPY (trailed the market by 7.4%).